| Zhang, Bingzhong |
| Not yet recruiting | 3 | 420 | RoW | Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Cancer | 12/27 | 06/29 | | |
TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer |
|
|
| Recruiting | 2 | 196 | RoW | TQB2450, Anlotinib | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer | 12/21 | 04/22 | | |
NCT05112991: Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer |
|
|
| Recruiting | 2 | 108 | RoW | Envafolimab+Lenvatinib, Envafolimab | 3D Medicines (Sichuan) Co., Ltd. | Advanced Endometrial Cancer | 03/25 | 10/25 | | |
TQB2450-II-14, NCT05481645: Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. |
|
|
| Recruiting | 2 | 79 | RoW | TQB2450 injection, Anlotinib Hydrochloride Capsule, Carboplatin Injection, Paclitaxel Injection, Doxorubicin Hydrochloride Injection, Gemcitabine Hydrochloride Injection, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer, Sarcoma of Uterus | 06/24 | 12/24 | | |
NCT05866354: To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies |
|
|
| Completed | 1 | 19 | RoW | Tisotumab Vedotin | Zai Lab (Shanghai) Co., Ltd. | Solid Malignancies | 11/23 | 11/23 | | |
NCT06083779: Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics |
|
|
| Recruiting | N/A | 216 | RoW | low-depth whole-genome sequencing technology | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Nanjing Geneseeq Technology Inc. | Endometrial Cancer | 01/24 | 04/24 | | |
NCT05693974: Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study) |
|
|
| Active, not recruiting | N/A | 130 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Nanjing Geneseeq Technology Inc. | Ovarian Cancer | 01/23 | 04/23 | | |
NCT05693987: Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study) |
|
|
| Recruiting | N/A | 248 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Nanjing Geneseeq Technology Inc. | Ovarian Cancer | 02/23 | 04/23 | | |
| Qunxian, Rao |
NCT05693987: Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study) |
|
|
| Recruiting | N/A | 248 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Nanjing Geneseeq Technology Inc. | Ovarian Cancer | 02/23 | 04/23 | | |
| Lu, huaiwu |
| Recruiting | N/A | 168 | RoW | Blood collection | Fudan University, Shanghai Weihe Medical Laboratory Co., Ltd. | Ovarian Cancer | 12/25 | 12/26 | | |
